+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Trimethoprim"

From
From
Urinary Tract Infection Treatment Global Market Report 2024 - Product Thumbnail Image

Urinary Tract Infection Treatment Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
From
US Urinary Tract Infection Therapeutics outlook to 2028 - Product Thumbnail Image

US Urinary Tract Infection Therapeutics outlook to 2028

  • Report
  • August 2023
  • 85 Pages
  • United States
From
From
From
  • 10 Results (Page 1 of 1)
Loading Indicator

Trimethoprim is a urological disorder drug used to treat a variety of urinary tract infections. It is a synthetic antibacterial agent that works by inhibiting the production of dihydrofolic acid, which is necessary for bacterial growth. It is often used in combination with sulfamethoxazole to treat infections caused by bacteria. Trimethoprim is available in both oral and intravenous forms and is generally well tolerated. Common side effects include nausea, vomiting, and diarrhea. Trimethoprim is a widely used drug in the urological disorder market, as it is effective in treating a variety of urinary tract infections. It is often prescribed in combination with other drugs to treat more severe infections. It is also used to prevent urinary tract infections in patients who are at risk of developing them. Some companies in the trimethoprim market include Pfizer, Merck, GlaxoSmithKline, and AstraZeneca. Show Less Read more